Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Update Il y a 4 ans
Reference: NCT00121095

Extract

The purpose of this study is to investigate the safety, tolerability and anti-tumor effects of treatment with samarium Sm-153 lexidronam in combination with docetaxel in patients with castrate metastatic prostate cancer.


Inclusion criteria

  • Prostatic Neoplasms

Links